Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health
Reference22 articles.
1. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D . Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; 21 (1): CD004661.
2. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M . Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350 (9090): 1517–1518.
3. Crowther CA, Hiller JE, Doyle LW, Haslam RR, Australian Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J Am Med Assoc 2003; 290: 2669–2676.
4. Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, Delaporte B et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008; 36 (3): 278–288.
5. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359: 895–905.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献